Early research (Phase 1)Study completedNCT06206824
What this trial is testing
Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease
Who this might be right for
Healthy VolunteersDown SyndromeAlzheimer's Disease
Perha Pharmaceuticals 152